Total Funding
1
Total FundingSeed raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3835806
Prismic Pharmaceuticals is focused on developing novel prescription medical drugs for the treatment of inflammatory diseases.
Teo Forcht Dagi: MD, EVP, Chief Medical Officer- Patrick Miller: EVP
About the Company
Prismic Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing novel prescription medical foods for the clinical dietary management of the metabolic processes associated with disorders commonly seen in the aging “baby boomer” population. These include disorders of the central nervous system (CNS), as well as conditions
where inflammation is an underlying or significant cause of the disorder..
The company's initial product candidates are focused on the use of a highly purified form of Omega-3 fatty acids in combination with other molecules for the treatment of CNS disorders, and are protected by a series of issued U.S. and foreign composition and use patents.
